These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 25851619)

  • 1. Selective disruption of heparin and antithrombin-mediated regulation of human factor IX.
    Westmark PR; Tanratana P; Sheehan JP
    J Thromb Haemost; 2015 Jun; 13(6):1053-63. PubMed ID: 25851619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low molecular weight heparin inhibits plasma thrombin generation via direct targeting of factor IXa: contribution of the serpin-independent mechanism.
    Buyue Y; Misenheimer TM; Sheehan JP
    J Thromb Haemost; 2012 Oct; 10(10):2086-98. PubMed ID: 22905983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticoagulant Protein S Targets the Factor IXa Heparin-Binding Exosite to Prevent Thrombosis.
    Plautz WE; Sekhar Pilli VS; Cooley BC; Chattopadhyay R; Westmark PR; Getz T; Paul D; Bergmeier W; Sheehan JP; Majumder R
    Arterioscler Thromb Vasc Biol; 2018 Apr; 38(4):816-828. PubMed ID: 29419409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The heparin-binding exosite is critical to allosteric activation of factor IXa in the intrinsic tenase complex: the role of arginine 165 and factor X.
    Misenheimer TM; Buyue Y; Sheehan JP
    Biochemistry; 2007 Jul; 46(26):7886-95. PubMed ID: 17563121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The regulation of factor IXa by supersulfated low molecular weight heparin.
    Misenheimer TM; Sheehan JP
    Biochemistry; 2010 Nov; 49(46):9997-10005. PubMed ID: 20945941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Residues Tyr253 and Glu255 in strand 3 of beta-sheet C of antithrombin are key determinants of an exosite made accessible by heparin activation to promote rapid inhibition of factors Xa and IXa.
    Izaguirre G; Olson ST
    J Biol Chem; 2006 May; 281(19):13424-13432. PubMed ID: 16517611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression and Characterization of Gly-317 Variants of Factor IX Causing Variable Bleeding in Hemophilia B Patients.
    Lu Q; Yang L; Manithody C; Wang X; Rezaie AR
    Biochemistry; 2015 Jun; 54(24):3814-21. PubMed ID: 26023895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conformational activation of antithrombin by heparin involves an altered exosite interaction with protease.
    Izaguirre G; Aguila S; Qi L; Swanson R; Roth R; Rezaie AR; Gettins PG; Olson ST
    J Biol Chem; 2014 Dec; 289(49):34049-64. PubMed ID: 25331949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression and characterization of a novel human recombinant factor IX molecule with enhanced in vitro and in vivo clotting activity.
    Perot E; Enjolras N; Le Quellec S; Indalecio A; Girard J; Negrier C; Dargaud Y
    Thromb Res; 2015 May; 135(5):1017-24. PubMed ID: 25795563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factor IXa variants resistant to plasma inhibitors enhance clot formation in vivo.
    Ivanciu L; Arruda VR; Camire RM
    Blood; 2023 Apr; 141(16):2022-2032. PubMed ID: 36724452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measurement of factor IX activity in plasma-derived and recombinant concentrates: insights from thrombin generation and activation-based assays.
    Yu Y; Millar CM
    J Thromb Haemost; 2014 Jan; 12(1):62-70. PubMed ID: 24215160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The factor IXa heparin-binding exosite is a cofactor interactive site: mechanism for antithrombin-independent inhibition of intrinsic tenase by heparin.
    Yuan QP; Walke EN; Sheehan JP
    Biochemistry; 2005 Mar; 44(9):3615-25. PubMed ID: 15736971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An interactive mutation database for human coagulation factor IX provides novel insights into the phenotypes and genetics of hemophilia B.
    Rallapalli PM; Kemball-Cook G; Tuddenham EG; Gomez K; Perkins SJ
    J Thromb Haemost; 2013 Jul; 11(7):1329-40. PubMed ID: 23617593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changing residue 338 in human factor IX from arginine to alanine causes an increase in catalytic activity.
    Chang J; Jin J; Lollar P; Bode W; Brandstetter H; Hamaguchi N; Straight DL; Stafford DW
    J Biol Chem; 1998 May; 273(20):12089-94. PubMed ID: 9575152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Localization of an antithrombin exosite that promotes rapid inhibition of factors Xa and IXa dependent on heparin activation of the serpin.
    Izaguirre G; Zhang W; Swanson R; Bedsted T; Olson ST
    J Biol Chem; 2003 Dec; 278(51):51433-40. PubMed ID: 14532267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monitoring once-weekly recombinant factor IX prophylaxis in hemophilia B with thrombin generation assay and factor IX activity.
    Nummi V; Jouppila A; Lassila R
    Int J Lab Hematol; 2017 Aug; 39(4):359-368. PubMed ID: 28406575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The heparin-binding exosite of factor IXa is a critical regulator of plasma thrombin generation and venous thrombosis.
    Buyue Y; Whinna HC; Sheehan JP
    Blood; 2008 Oct; 112(8):3234-41. PubMed ID: 18647957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The allosteric mechanism of activation of antithrombin as an inhibitor of factor IXa and factor Xa: heparin-independent full activation through mutations adjacent to helix D.
    Dementiev A; Swanson R; Roth R; Isetti G; Izaguirre G; Olson ST; Gettins PGW
    J Biol Chem; 2013 Nov; 288(47):33611-33619. PubMed ID: 24068708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular basis of factor IXa recognition by heparin-activated antithrombin revealed by a 1.7-A structure of the ternary complex.
    Johnson DJ; Langdown J; Huntington JA
    Proc Natl Acad Sci U S A; 2010 Jan; 107(2):645-50. PubMed ID: 20080729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fucosylated chondroitin sulfate inhibits plasma thrombin generation via targeting of the factor IXa heparin-binding exosite.
    Buyue Y; Sheehan JP
    Blood; 2009 Oct; 114(14):3092-100. PubMed ID: 19414859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.